Rankings
▼
Calendar
ANIK FY 2018 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
FY 2018 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$106M
-6.9% YoY
Gross Profit
$74M
70.4% margin
Operating Income
$22M
20.6% margin
Net Income
$19M
17.7% margin
EPS (Diluted)
$1.27
Cash Flow
Operating Cash Flow
$35M
Free Cash Flow
$30M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$279M
Total Liabilities
$15M
Stockholders' Equity
$264M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$106M
$113M
-6.9%
Gross Profit
$74M
$86M
-13.7%
Operating Income
$22M
$46M
-52.4%
Net Income
$19M
$32M
-41.2%
← Q4 2017
All Quarters
Q1 2018 →